clinical trial · NCT03531255
Pegcetacoplan Long Term Safety and Efficacy Extension Study
PNHPegcetacoplan
brief summary
This is an Open-label, Non-Randomized, Multi-Center Extension Study. Eligible subjects will have previously completed a pegcetacoplan study.
started
Aug 27, 2018
primary completion
Sep 4, 2025
completion
May 19, 2026
last updated
Jun 5, 2026
official title
An Open Label, Non-Randomized, Multi-Center Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol